Effect of TPA and HTLV-1 Tax on BRCA1 and ERE controlled genes expression

References

• Yoshida M. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 2005; 24:5931-7; PMID:16155600; https://doi.org/10.1038/sj.onc.1208981
   PubMed Web of Science ®Google Scholar
• Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, Tsugane S. Tobacco smoking and breast cancer risk: An evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol 2006; 36:387-94; PMID:16766567; https://doi.org/10.1093/jjco/hyl031
   PubMed Web of Science ®Google Scholar
• Shrubsole MJ, Gao YT, Dai Q, Shu XO, Ruan ZX, Jin F, Zheng W. Passive smoking and breast cancer risk among non-smoking Chinese women. Int J Cancer 2004; 110:605-9; PMID:15122595; https://doi.org/10.1002/ijc.20168
   PubMed Web of Science ®Google Scholar
• Coyle YM. The effect of environment on breast cancer risk. Breast Cancer Res Treat 2004; 84:273-88; PMID:15026625; https://doi.org/10.1023/B:BREA.0000019964.33963.09
   PubMed Web of Science ®Google Scholar
• Snedeker SM. Chemical exposures in the workplace: effect on breast cancer risk among women. AAOHN J 2006; 54:270-9; PMID:16800404; https://doi.org/10.1177/216507990605400604
   PubMedGoogle Scholar
• Bernstein L, Patel AV, Ursin G, Sullivan-Halley J, Press MF, Deapen D, Berlin JA, Daling JR, McDonald JA, Norman SA, et al. Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst 2005; 97:1671-9; PMID:16288120; https://doi.org/10.1093/jnci/dji374
   PubMed Web of Science ®Google Scholar
• Ganmaa D, Willett WC, Li TY, Feskanich D, van Dam RM, Lopez-Garcia E, Hunter DJ, Holmes MD. Coffee, tea, caffeine and risk of breast cancer: A 22-year follow-up. Int J Cancer 2008; 122:2071-6; PMID:18183588; https://doi.org/10.1002/ijc.23336
   PubMed Web of Science ®Google Scholar
• Dumitrescu RG, Shields PG. The etiology of alcohol-induced breast cancer. Alcohol 2005; 35:213-25; PMID:16054983; https://doi.org/10.1016/j.alcohol.2005.04.005
   PubMed Web of Science ®Google Scholar
• Emery J, Lucassen A, Murphy M. Common hereditary cancers and implications for primary care. The Lancet 2001; 358:56-63; https://doi.org/10.1016/S0140-6736(00)05257-0
   PubMed Web of Science ®Google Scholar
• Sunpaweravong S, Sunpaweravong P. Recent developments in critical genes in the molecular biology of breast cancer. Asian J Surg 2005; 28:71-5; PMID:15691805; https://doi.org/10.1016/S1015-9584(09)60265-7
   PubMedGoogle Scholar
• Yarden RI, Papa MZ. BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions. Mol Cancer Ther 2006; 5:1396-404; PMID:16818497; https://doi.org/10.1158/1535-7163.MCT-05-0471
   PubMed Web of Science ®Google Scholar
• Rosen EM, Fan S, Isaacs C. BRCA1 in hormonal carcinogenesis: basic and clinical research. Endocr Relat Cancer 2005; 12:533-48; PMID:16172191; https://doi.org/10.1677/erc.1.00972
   PubMed Web of Science ®Google Scholar
• Wu W, Koike A, Takeshita T, Ohta T. The ubiquitin E3 ligase activity of BRCA1 and its biological functions. Cell Div 2008; 3:1-10; PMID:18179693; https://doi.org/10.1186/1747-1028-3-1
   PubMed Web of Science ®Google Scholar
• Deng CX. Roles of BRCA1 in centrosome duplication. Oncogene 2002; 21:6222-7; PMID:12214252; https://doi.org/10.1038/sj.onc.1205713
   PubMed Web of Science ®Google Scholar
• Yun MH, Hiom K. Understanding the functions of BRCA1 in the DNA-damage response. Biochem Soc Trans 2009; 37:597-604; PMID:19442256; https://doi.org/10.1042/BST0370597
   PubMed Web of Science ®Google Scholar
• Zhang J, Powell SN. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res 2005; 3:531-9; PMID:16254187; https://doi.org/10.1158/1541-7786.MCR-05-0192
   PubMed Web of Science ®Google Scholar
• Hartman AR, Ford JM. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat Genet 2002; 32:180-4; PMID:12195423; https://doi.org/10.1038/ng953
   PubMed Web of Science ®Google Scholar
• Ye Q, Hu Y-F, Zhong H, Nye AC, Belmont AS, Li R. BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J Cell Biol 2001; 155:911-22; PMID:11739404; https://doi.org/10.1083/jcb.200108049
   PubMed Web of Science ®Google Scholar
• Xu B, Kim S-T, Kastan MB. Involvement of Brca1 in S-phase and G2-phase checkpoints after ionizing irradiation. Mol Cell Biol 2001; 21:3445-50; PMID:11313470; https://doi.org/10.1128/MCB.21.10.3445-3450.2001
   PubMed Web of Science ®Google Scholar
• Thangaraju M, Kaufmann SH, Couch FJ. BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines. J Biol Chem 2000; 275:33487-96; PMID:10938285; https://doi.org/10.1074/jbc.M005824200
   PubMed Web of Science ®Google Scholar
• Parvin JD. BRCA1 at a branch point. Proc Natl Acad Sci USA 2001; 98:5952-4; PMID:11371630; https://doi.org/10.1073/pnas.121184998
   PubMed Web of Science ®Google Scholar
• Rosen EM, Fan S, Pestell RG, Goldberg ID. BRCA1 gene in breast cancer. J Cell Physiol 2003; 196:19-41; PMID:12767038; https://doi.org/10.1002/jcp.10257
   PubMed Web of Science ®Google Scholar
• Baldassarre G, Battista S, Belletti B, Thakur S, Pentimalli F, Trapasso F, Fedele M, Pierantoni G, Croce CM, Fusco A. Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol Cell Biol 2003; 23:2225-38; PMID:12640109; https://doi.org/10.1128/MCB.23.7.2225-2238.2003
   PubMed Web of Science ®Google Scholar
• Thakur S, Nakamura T, Calin G, Russo A, Tamburrino JF, Shimizu M, Baldassarre G, Battista S, Fusco A, Wassell RP, et al. Regulation of BRCA1 transcription by specific single-stranded DNA binding factors. Mol Cell Biol 2003; 23:3774-87; PMID:12748281; https://doi.org/10.1128/MCB.23.11.3774-3787.2003
   PubMed Web of Science ®Google Scholar
• Catteau A, Harris WH, Xu CF, Solomon E. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 1999; 18:1957-65; PMID:10208417; https://doi.org/10.1038/sj.onc.1202509
   PubMed Web of Science ®Google Scholar
• Mueller CR, Roskelley CD. Regulation of BRCA1 expression and its relationship to sporadic breast cancer. Breast Cancer Res 2003; 5:45-52; PMID:12559046; https://doi.org/10.1186/bcr557
   PubMed Web of Science ®Google Scholar
• Taylor J, Lymboura M, Pace PE, A'hern RP, Desai AJ, Shousha S, Coombes RC, Ali S. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. International Journal of Cancer 1998; 79:334-42; PMID:9699523; https://doi.org/10.1002/(SICI)1097-0215(19980821)79:4<334::AID-IJC5>3.0.CO;2-W
   PubMed Web of Science ®Google Scholar
• Girault I, Bieche I, Lidereau R. Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer. Maturitas 2006; 54:342-51; PMID:16822624; https://doi.org/10.1016/j.maturitas.2006.06.003
   PubMed Web of Science ®Google Scholar
• Jeffy BD, Hockings JK, Kemp MQ, Morgan SS, Hager JA, Beliakoff J, Whitesell LJ, Bowden GT, Romagnolo DF. An estrogen receptor-α/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription. Neoplasia 2005; 7:873-82; PMID:16229810; https://doi.org/10.1593/neo.05256
   PubMed Web of Science ®Google Scholar
• Marks JR, Huper G, Vaughn JP, Davis PL, Norris J, McDonnell DP, Wiseman RW, Futreal PA, Iglehart JD. BRCA1 expression is not directly responsive to estrogen. Oncogene 1997; 14:115-21; PMID:9010238; https://doi.org/10.1038/sj.onc.1200808
   PubMed Web of Science ®Google Scholar
• Hockings JK, Degner SC, Morgan SS, Kemp MQ, Romagnolo DF. Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene. Breast Cancer Res 2008; 10:R29. (31 March 2008); PMID:18377656; https://doi.org/10.1186/bcr1987
   PubMed Web of Science ®Google Scholar
• Hockings JK, Thorne PA, Kemp MQ, Morgan SS, Selmin O, Romagnolo DF. The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen. Cancer Res 2006; 66:2224-32; PMID:16489025; https://doi.org/10.1158/0008-5472.CAN-05-1619
   PubMed Web of Science ®Google Scholar
• Wang W, Schneider-Broussard R, Kumar A, MacLeod M, Johnson D. Regulation of BRCA1 Expression by the Rb-E2F Pathway. J Biol Chem 2000; 275:4532-6; PMID:10660629; https://doi.org/10.1074/jbc.275.6.4532
   PubMed Web of Science ®Google Scholar
• Corkery D, Thillainadesan G, Coughlan N, Mohan RD, Isovic M, Tini M, Torchia J. Regulation of the BRCA1 gene by an SRC3/53BP1 complex. BMC Biochem 2011; 12:50-62; PMID:21914189; https://doi.org/10.1186/1471-2091-12-50
   PubMed Web of Science ®Google Scholar
• Ohshima K. Pathological features of diseases associated with human T-cell leukemia virus type I. Cancer Sci 2007; 98:772-8; PMID:17388788; https://doi.org/10.1111/j.1349-7006.2007.00456.x
   PubMed Web of Science ®Google Scholar
• Azran I, Schavinsky-Khrapunsky Y, Aboud M. Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology 2004; 1:20-43; PMID:15310405; https://doi.org/10.1186/1742-4690-1-20
   PubMedGoogle Scholar
• Shukrun M, Jabareen A, Abu-akandil A, Chamias R, Aboud M, Huleihel M. HTLV-1 Tax oncoprotein inhibits the estrogen-induced BRCA1 exprestion through the ERalpha non-convetional transcriptional activation. Plos One 2014; 9(2):e89390; PMID:24586743; https://doi.org/10.1371/journal.pone.0089390
   PubMed Web of Science ®Google Scholar
• Hino S. Milk-borne transmission of HTLV-I as a major route in the endemic cycle. Acta Paediatr Jpn 1989; 31:428-35; PMID:2514566; https://doi.org/10.1111/j.1442-200X.1989.tb01329.x
   PubMedGoogle Scholar
• Wiktor SZ, Pate EJ, Rosenberg PS, Barnett M, Palmer P, Medeiros D, Maloney EM, Blattner WA. Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol 1997; 1:37-44; PMID:10195229
   PubMedGoogle Scholar
• Li HC, Biggar RJ, Miley WJ, Maloney EM, Cranston B, Hanchard B, Hisada M. Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis 2004; 190:1275-8; PMID:15346338; https://doi.org/10.1086/423941
   PubMed Web of Science ®Google Scholar
• Ureta-Vidal A, Angelin-Duclos C, Tortevoye P, Murphy E, Lepère JF, Buigues RP, Jolly N, Joubert M, Carles G, Pouliquen JF, et al. Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothers. Int J Cancer 1999; 82:832-6; PMID:10446450; https://doi.org/10.1002/(SICI)1097-0215(19990909)82:6<832::AID-IJC11>3.0.CO;2-P
   PubMed Web of Science ®Google Scholar
• Southern SO, Southern PJ. Persistent HTLV-I infection of breast luminal epithelial cells: a role in HTLV transmission? Virology 1998; 241:200-14; PMID:9499795; https://doi.org/10.1006/viro.1997.8978
   PubMed Web of Science ®Google Scholar
• LeVasseur RJ, Southern SO, Southern PJ. Mammary epithelial cells support and transfer productive human T-cell lymphotropic virus infections. J Hum Virol 1998; 1:214-23; PMID:10195245
   PubMedGoogle Scholar
• Southern S, Southern P. Cellular mechanism for milk-borne transmission of HIV and HTLV. Adv Exp Med Biol 2002; 503:183-90; PMID:12026019
   PubMed Web of Science ®Google Scholar
• Hecker E, Schmidt R. Phorbolesters–the irritants and cocarcinogens of Croton Tiglium L. Fortschr Chem Org Naturst 1974; 31:377-467; PMID:4609865
   PubMedGoogle Scholar
• Ito I, Matsuda S, Tokudo H, Nakao Y. Tumor promoting diterpen esters as possible environmental co-factors for ATL. In: R.C. Gallo, ME, L. Gross, ed. Human T-cell leukemia/lymphoma virus and adult T-cell leukemia. New York: Cold Spring Harbor, Cold Spring Harbor, 1984:69-74
   Google Scholar
• Jones K. Review of Sangre de Drago (Croton lechleri) - A South American tree sap in the treatment of diarrhea, inflammation, insect bites, viral infections, and wounds: Traditional uses to clinical research. J Alternat Complement Med 2003; 9:877-96; https://doi.org/10.1089/107555303771952235
   PubMed Web of Science ®Google Scholar
• Matsuda S, Nakao Y, Ohigashi H, Koshimizu K, Ito Y. Plant-derived diterpene esters enhance HTLV-I-induced colony formation of lymphocytes in co-culture. Int J Cancer 1986; 38:859-65; PMID:3025104; https://doi.org/10.1002/ijc.2910380613
   PubMed Web of Science ®Google Scholar
• Nakao Y, Matsuda S, Matusi T, Nakagawa T, Fujita T, Uchiyama T, Maeda S, Okamoto Y, Masaoka T, Ito I. Effect of tumor promoters on human T-cell leukemia/lymphoma (HTLV)-structural protein induction in adult T-cell leukemia cells. Cancer Lett 1984; 24:129-39; PMID:6090008; https://doi.org/10.1016/0304-3835(84)90128-9
   PubMed Web of Science ®Google Scholar
• Williams JE. Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Una de Gato and Sangre de Grado. Altern Med Rev 2001; 6:567-79
   PubMedGoogle Scholar
• Kim S, Chun S-Y, Kwon Y-S, Nam K-S. Crosstalk between Wnt signaling and Phorbol ester-mediated PKC signaling in MCF-7 human breast cancer cells. Biomed Pharmacother 2016; 77:114-9; https://doi.org/10.1016/j.biopha.2015.12.008
   PubMed Web of Science ®Google Scholar
• Barry OP, Kazanietz MG. Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy. Curr Pharm Design 2001; 7:1725-44; https://doi.org/10.2174/1381612013397041
   PubMed Web of Science ®Google Scholar
• Nakao Y, Matsuda S, Matsui T, Koizumi T, Katakami Y, Fujita T, Y I. Inhibitors of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced multinucleated cell formation and HTLV-I p19 antigen expression in HTLV-I-infected T-cell line KH-2Lo. Int J Cancer 1986; 37:911-7; PMID:3011686; https://doi.org/10.1002/ijc.2910370618
   PubMed Web of Science ®Google Scholar
• Lacroix M, Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat Feb 2004; 83:249-89; https://doi.org/10.1023/B:BREA.0000014042.54925.cc
   PubMed Web of Science ®Google Scholar
• Veprik A, Khanin M, Hermoni KL, Danilenko M, Levy Y. Y. S. Polyphenols, isothiocyanates and carotenoid derivatives enhance estrogenic activity in bone cells but inhibit it in breast cancer cells. Am J Physiol Endocrinol Metab 2011: Aug 30. [Epub ahead of print]; PMID:21878663
   PubMed Web of Science ®Google Scholar
• Bartholin L, Guindon S, Martel S, Corbo L, Rimokh R. Identification of NF-κB responsive elements in follistatin related gene (FLRG) promoter. Gene Dev 2007; 393:153-62
   Google Scholar
• Mor-Vaknin N, Torgeman A, Galron D, Lochelt M, Flugel RM, Aboud M. The long terminal repeats of human immunodeficiency virus type-1 and human T-cell leukemia virus type-I are activated by 12-O-tetradecanoylphorbol-13-acetate through different pathways. Virology 1997; 232:337-44; PMID:9191847; https://doi.org/10.1006/viro.1997.8566
   PubMed Web of Science ®Google Scholar
• Torgeman A, Mor-Vaknin N, Zelin E, Ben-Aroya Z, Lochelt M, Flugel RM, Aboud M. Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C. Virology 2001; 281:10-20; PMID:11222091; https://doi.org/10.1006/viro.2000.0779
   PubMed Web of Science ®Google Scholar
• Abou-Kandil A, Eisa N, Jabareen A, Huleihel M. Differential effects of HTLV-1 Tax oncoprotein on the different estrogen-induced-ER α-mediated transcriptional activities. Cell Cycle 2016; 15:1208871; https://doi.org/10.1080/15384101.2016.1208871
   Web of Science ®Google Scholar
• Abou-Kandil A, Chamias R, Huleihel M, Godbey WT, Aboud M. Differential Role of PKC-Induced c-Jun in HTLV-1 LTR Activation by 12-O-Tetradecanoylphorbol-13-acetate in Different Human T-cell Lines. PLoS ONE 2012; 7:e29934; PMID:22299029; https://doi.org/10.1371/journal.pone.0029934
   PubMed Web of Science ®Google Scholar
• Demizu Y, Misawa T, Nagakubo T, Kanda Y, Okuhira K, Sekino Y, Naito M, Kurihara M. Structural development of stabilized helical peptides as inhibitors of estrogen receptor (ER)-mediated transcription. Bioorg Med Chem 2015; 23:4132-8; https://doi.org/10.1016/j.bmc.2015.06.067
   PubMed Web of Science ®Google Scholar
• Chung M-H, Kim D-H, Na H-K, Kim J-H, Kim H-N, Haegeman G, Surh Y-J. Genistein inhibits phorbol ester-induced NF-κB transcriptional activity and COX-2 expression by blocking the phosphorylation of p65/RelA in human mammary epithelial cells. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2014; 768:74-83; https://doi.org/10.1016/j.mrfmmm.2014.04.003
   PubMed Web of Science ®Google Scholar
• Tanaka K, Kawakami T, Tateishi K, Yashiroda H, Chiba T. Control of IκBα proteolysis by the ubiquitin-proteasome pathway. Biochimie 2001; 83:351-6; PMID:11295496; https://doi.org/10.1016/S0300-9084(01)01237-8
   PubMed Web of Science ®Google Scholar
• Rauch T, Zhong X, Pfeifer GP, Xingzhi X. 53BP1 is a Positive Regulator of the BRCA1 Promoter. Cell Cycle 2005; 4(8):1078-83; PMID:15970701; https://doi.org/10.4161/cc.4.8.1855
   PubMed Web of Science ®Google Scholar
• Arisawa K, Soda M, M A, Fujiwara S UH, M H, Takeda H, Kashino W, Suyama A. Human T-cell lymphotropic virus type-1 infection and risk of cancer: 15.4 year longitudinal study among atomic bomb survivors in Nagasaki, Japan. Cancer Sci 2006; 97:535-9; PMID:16734733; https://doi.org/10.1111/j.1349-7006.2006.00212.x
   PubMed Web of Science ®Google Scholar
• Nutt JE, Harris AL, Lunec J. Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells. British Journal of Cancer 1991; 64:671-6; PMID:1911215; https://doi.org/10.1038/bjc.1991.379
   PubMed Web of Science ®Google Scholar
• Inadera H. Estrogen-induced genes, WISP-2 and pS2, respond divergently to protein kinase pathway. Biochem Biophys Res Commun 2003; 309:272-8; PMID:12951045; https://doi.org/10.1016/j.bbrc.2003.07.001
   PubMed Web of Science ®Google Scholar
• Beck S, Fegert P, Gott P. Factors regulating pS2-reporter gene expression in MCF-7 breast cancer cell line. Int J Oncol 1997; 10(5):1051-5; PMID:21533484
   PubMed Web of Science ®Google Scholar
• Cho H, Katzenellenbogen BS. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol Endocrinol 1993; 7(3):441-52; PMID:7683375; https://doi.org/10.1210/mend.7.3.7683375 10.1210/me.7.3.441
   PubMed Web of Science ®Google Scholar
• Martin MB, Garcia-Morales P, Stoica A, Solomon HB, Pierce M, Katz D, Zhang S, Danielsen M, Saceda M. Effects of 12-O-tetradecanoylphorbol-13-acetate on estrogen receptor activity in MCF-7 cells. J Biol Chem 1995; 270(42):25244-51; PMID:7559663; https://doi.org/10.1074/jbc.270.42.25244
   PubMed Web of Science ®Google Scholar
• Weigel NL, Zhang Y. Ligand-independent activation of steroid hormone receptors. J Mol Med (Berl) 1998; 76(7):469-79; PMID:9660165; https://doi.org/10.1007/s001090050241
   PubMed Web of Science ®Google Scholar
• Göttlicher M, Heck S, Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med (Berl) 1998; 76(7):480-9; PMID:9660166; https://doi.org/10.1007/s001090050242
   PubMed Web of Science ®Google Scholar